@ARTICLE{
author={Pillai Rathi N,Fennell Dean A,Kovcin Vladimir N,Ciuleanu Tudor E,Ramlau Rodryg,Kowalski Dariusz,Schenker Michael,Yalcin Ilker,Teofilovici Florentina,Vukovic Vojo M,Ramalingam Suresh S},
year={2020},
title={Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2)},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={38},
number={6},
pages={613-+},
document_type={Article},
} 

@ARTICLE{
author={Schwartzberg Lee Steven,Roeland E,Andric Zoran G,Kowalski Dariusz,Radic J,Voisin Daniel,Rizzi Giada,Navari R,Gralla Richard J,Karthaus Meinolf},
year={2018},
title={Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy},
journal={ANNALS OF ONCOLOGY},
volume={29},
number={7},
pages={1535-1540},
document_type={Article},
} 

@ARTICLE{
author={Schwartzberg Lee Steven,Andric Zoran G,Kowalski Dariusz,Voisin Daniel,Rizzi Giada,Karthaus Meinolf},
year={2017},
title={Phase III safety evaluation of intravenous NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron, over multiple cycles},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={35},
number={31},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Pillai Rathi N,Fennell Dean,Kovcin Vladimir N,Ciuleanu Tudor E,Ramlau Rodryg,Kowalski Dariusz,Schenker Michael,Perin Branislav M,Yalcin Ilker,Teofilovici Florentina,Vukovic Vojo M,Ramalingam Suresh S},
year={2017},
title={Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2)},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={12},
number={1},
pages={S7-S8},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Schwartzberg Lee Steven,Andric Zoran G,Kowalski Dariusz,Voisin Daniel,Rizzi Giada,Karthaus Meinolf},
year={2017},
title={Phase 3 safety evaluation of an intravenous formulation of NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron},
journal={ANNALS OF ONCOLOGY},
volume={28},
number={},
pages={-},
document_type={Meeting Abstract},
} 

